Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Clinical and Experimental Immunology|August 12, 1999
Encapsulation in hollow fibres of xenogeneic cells engineered to secrete IL-4 or IL-13 ameliorates murine collagen-induced arthritis (CIA)N Bessis, J Honiger, D Damotte, et al.European Journal of Immunology|December 22, 1999
Expression of Fas ligand improves the effect of IL-4 in collagen-induced arthritisL Guéry, F Batteux, N Bessis, et al.European Journal of Immunology|May 1, 1995
Biphasic effect of interferon-gamma in murine collagen-induced arthritisM C Boissier, G Chiocchia, N Bessis, et al.Clinical and Experimental Immunology|March 5, 1998
Modulation of proinflammatory cytokine production in tumour necrosis factor-alpha (TNF-alpha)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13N Bessis, G Chiocchia, G Kollias, et al.The Journal of Gene Medicine|October 4, 2007
Intra-articular electrotransfer of plasmid encoding soluble TNF receptor variants in normal and arthritic miceC Bloquel, A Denys, M C Boissier, et al.Human Gene Therapy|May 30, 2007
Synoviocyte infection with adeno-associated virus (AAV) is neutralized by human synovial fluid from arthritis patients and depends on AAV serotypeM-C Boissier, D Lemeiter, C Clavel, et al.European Journal of Immunology|March 31, 2000
The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritisN Bessis, L Guéry, A Mantovani, et al.Annals of the Rheumatic Diseases|November 29, 2007
Early and long-lasting protection from arthritis in tumour necrosis factor alpha (TNFalpha) transgenic mice vaccinated against TNFalphaL Delavallée, H Le Buanec, N Bessis, et al.Cytokine|July 16, 2014
Interleukin-35 gene therapy exacerbates experimental rheumatoid arthritis in miceA Thiolat, A Denys, M Petit, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1997
High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptorsB Manoury-Schwartz, G Chiocchia, N Bessis, et al.Pageof 3